The advanced matrix fentanyl patch Matrifen® eases severe chronic pain

The advanced matrix fentanyl patch Matrifen® from Nycomed with fentanyl gives excelent pain relief for patients with severe chronic pain.

The advanced matrix transdermal fentanyl patch Matrifen® is a patch, which provides relief for patients with severe chronic pain.

>> Information on the advanced matrix fentanyl patch Matrifen®

Matrifen®’s unique and advanced matrix technology provides 72-hour pain relief equal to that of other matrix fentanyl patches, but with a lower drug load making it a more environmentally friendly medication.

Matrifen is a potent analgesic, approximately 50 to 100 times as potent as morphine. Matrifen contains fentanyl, which belongs to the group of opioids, and transdermal fentanyl has been shown to have fewer side effects compared to morphine tablets and other oral formulations of opiod analgesics.

About Nycomed
Nycomed is a young company with a long history. Founded in 1874 in Norway by Morten Nyegaard, the company gradually began to expand into Europe, forming a strong position initially in the Nordic countries.

The modern story really begins in 1999, when Nycomed was established as a European company with a focus on sourcing and developing new pharmaceutical products. With this in place, the pace of this market expansion increased and the company now operates throughout Europe.

Fentanyl patch technology | Transdermal application | Steady-state concentration of fentanyl